Detalhe da pesquisa
1.
BAP1 is a novel regulator of HIF-1α.
Proc Natl Acad Sci U S A
; 120(4): e2217840120, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36656861
2.
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinoma.
Eur J Immunol
; 54(2): e2350637, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990855
3.
Detection of disease-causing mutations in prostate cancer by NGS sequencing.
Cell Biol Int
; 46(7): 1047-1061, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347810
4.
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study.
Int J Mol Sci
; 23(15)2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955679
5.
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing.
World J Microbiol Biotechnol
; 39(1): 37, 2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36472670
6.
Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture.
BMC Microbiol
; 20(1): 120, 2020 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423437
7.
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study.
Eur J Cancer Care (Engl)
; 28(6): e13137, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412428
8.
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
Br J Haematol
; 181(2): 229-233, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611195
9.
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma.
Br J Dermatol
; 188(5): 680-681, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36738251
10.
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations.
Genes Chromosomes Cancer
; 54(12): 818-26, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355802
11.
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes.
J Cell Physiol
; 230(4): 806-12, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25205602
12.
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.
BMC Cancer
; 15: 808, 2015 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508446
13.
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.
Blood
; 129(26): 3495-3498, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28446433
14.
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
Mol Cancer
; 12(1): 130, 2013 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24165569
15.
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.
Hepatology
; 56(3): 1025-33, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473819
16.
Novel Virus Identification through Metagenomics: A Systematic Review.
Life (Basel)
; 12(12)2022 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36556413
17.
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models.
Mol Ther Nucleic Acids
; 30: 347-349, 2022 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36381578
18.
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models.
Mol Ther Nucleic Acids
; 29: 538-549, 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36035756
19.
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy.
Cancers (Basel)
; 14(15)2022 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954369
20.
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Mol Cancer Ther
; 21(1): 58-69, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667115